Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Arcus Biosciences, Inc. (RCUS) had Receiveable Turnover of 1.87 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$28.00M |
|
$-112.00M |
|
-- |
|
$28.00M |
|
$150.00M |
|
$-122.00M |
|
$10.00M |
|
$-112.00M |
|
$-112.00M |
|
$-112.00M |
|
$-112.00M |
|
$-112.00M |
|
$-112.00M |
|
$-122.00M |
|
$-123.00M |
|
98.40M |
|
98.40M |
|
$-1.14 |
|
$-1.14 |
|
| Balance Sheet Financials | |
$1.03B |
|
$46.00M |
|
$125.00M |
|
$1.16B |
|
$192.00M |
|
$48.00M |
|
$433.00M |
|
$625.00M |
|
$531.00M |
|
$531.00M |
|
$531.00M |
|
105.90M |
|
| Cash Flow Statement Financials | |
$-132.00M |
|
$32.00M |
|
$142.00M |
|
$153.00M |
|
$195.00M |
|
$42.00M |
|
$16.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.37 |
|
-- |
|
-- |
|
0.08 |
|
0.09 |
|
100.00% |
|
-435.71% |
|
-435.71% |
|
-- |
|
-400.00% |
|
-400.00% |
|
$-133.00M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
|
Receiveable Turnover |
1.87 |
48.21 |
|
-21.09% |
|
-21.09% |
|
-9.69% |
|
-19.34% |
|
$5.01 |
|
$-1.35 |
|
$-1.34 |
|